Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cognetti

Showing results (1-10 of 275) with videos related to

Pageof 28
Sort By:
Critical Reviews in Oncology/Hematology|December 25, 2003
New drugs in the treatment of recurrent or metastatic cervical cancerAntonella Savarese, Francesco Cognetti
Oncotarget|December 30, 2021
The clinician's perspective on the 21-gene assay in early breast cancerFrancesco Cognetti, Giuseppe Naso
Breast Cancer Research and Treatment|November 24, 2021
Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx studySandro Barni, Francesco Cognetti, Fausto Petrelli
The Lancet. Oncology|March 8, 2016
Palbociclib: efficacious but predictive biomarkers still neededFrancesco Cognetti, Paola Malaguti, Daniele Alesini
Breast Cancer Research : BCR|December 19, 2007
The protective side of progesteroneGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
The New England Journal of Medicine|January 11, 2008
HER2 and response to paclitaxel in node-positive breast cancerGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
Journal of the National Cancer Institute|November 1, 2007
Re: Treatment of human epidermal growth factor receptor 2 overexpressing breast cancer xenografts with multiagent human epidermal growth factor receptor targeted therapyGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Can the reliance of hormone receptor assays of surgical specimens be explained by the fluctuation of estrogen receptor, progesterone receptor, and HER-2 protein expression in tumor samples of premenopausal breast cancer patients?Andrea Alimonti, Gianluigi Ferretti, Francesco Cognetti
Journal of the National Cancer Institute|April 5, 2007
Re: Age-related lobular involution and risk of breast cancerGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
Pregnancy levels of estrogen and progesterone: the double-edged swordGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
Pageof 28

Showing results (1-10 of 275) with videos related to

Sort By:
Pageof 28
Critical Reviews in Oncology/Hematology|December 25, 2003
New drugs in the treatment of recurrent or metastatic cervical cancerAntonella Savarese, Francesco Cognetti
Oncotarget|December 30, 2021
The clinician's perspective on the 21-gene assay in early breast cancerFrancesco Cognetti, Giuseppe Naso
Breast Cancer Research and Treatment|November 24, 2021
Is the oncotype DX test useful in elderly breast cancer patients: a subgroup analysis of real-life Italian PONDx studySandro Barni, Francesco Cognetti, Fausto Petrelli
The Lancet. Oncology|March 8, 2016
Palbociclib: efficacious but predictive biomarkers still neededFrancesco Cognetti, Paola Malaguti, Daniele Alesini
Breast Cancer Research : BCR|December 19, 2007
The protective side of progesteroneGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
The New England Journal of Medicine|January 11, 2008
HER2 and response to paclitaxel in node-positive breast cancerGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
Journal of the National Cancer Institute|November 1, 2007
Re: Treatment of human epidermal growth factor receptor 2 overexpressing breast cancer xenografts with multiagent human epidermal growth factor receptor targeted therapyGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Can the reliance of hormone receptor assays of surgical specimens be explained by the fluctuation of estrogen receptor, progesterone receptor, and HER-2 protein expression in tumor samples of premenopausal breast cancer patients?Andrea Alimonti, Gianluigi Ferretti, Francesco Cognetti
Journal of the National Cancer Institute|April 5, 2007
Re: Age-related lobular involution and risk of breast cancerGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 21, 2007
Pregnancy levels of estrogen and progesterone: the double-edged swordGianluigi Ferretti, Alessandra Felici, Francesco Cognetti
Pageof 28